Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health technology tags : Events save search
Thermo Fisher Scientific to Host Investor Day - April 24, 2024
Published: 2024-04-24 (Crawled : 12:00) - biospace.com/
TMO | News | $579.55 0.86% 350K
|
Health Technology
|
| O: 3.19%
H: 0.0%
C: 0.0%
day
Electromed, Inc. Schedules its Third Quarter Fiscal 2024 Financial Results Conference Call for May 7, 2024 at 5:00 p.m. ET
Published: 2024-04-23 (Crawled : 14:30) - biospace.com/
ELMD | $16.39 770
|
Health Technology
|
| O: 0.06%
H: 4.83%
C: 4.2%
conference for financial results
Ligand to Report First Quarter 2024 Financial Results on May 7, 2024
Published: 2024-04-23 (Crawled : 14:30) - biospace.com/
LGND | $69.72 -0.24% 3.7K
|
Health Technology
|
| O: -0.04%
H: 3.88%
C: 2.03%
first report financial results
Agenus to Provide First Quarter 2024 Financial Report and Corporate Update
Published: 2024-04-23 (Crawled : 12:00) - biospace.com/
AGEN A | $6.97 7.9% 330K
|
Health Technology
|
| O: 7.66%
H: 30.38%
C: 12.15%
first report update financial
CNS Pharmaceuticals to Participate in the Virtual Investor Lunch Break: The CNSP Opportunity
Published: 2024-04-22 (Crawled : 16:00) - biospace.com/
CNSP | News | $0.21 9.3K
|
Health Technology
|
| O: 0.0%
H: 5.0%
C: 0.0%
pharmaceuticals
Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society (ONS) Congress in Support of Company’s Expanding Focus on Cancer Supportive Care
Published: 2024-04-22 (Crawled : 14:00) - biospace.com/
JAGX | News | $0.1682 0.12% 16M
|
Health Technology
|
| O: 6.25%
H: 17.65%
C: 5.88%
health congress cancer care family
Outset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
Published: 2024-04-19 (Crawled : 14:00) - biospace.com/
OM | $2.57 4.47% 100K
|
Health Technology
|
| O: 3.24%
H: 6.28%
C: 4.04%
first report medical financial results
Aldeyra Therapeutics to Host Research & Development Day on April 25, 2024
Published: 2024-04-18 (Crawled : 12:00) - biospace.com/
ALDX | $3.945 0.9% 93K
|
Health Technology
|
| O: 1.53%
H: 2.52%
C: 0.25%
day research therapeutics development
Establishment Labs Announces Participation in The Aesthetic Meeting 2024
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
ESTA | $49.79 0.2% 1.5K
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: 0.0%
aesthetic meeting
Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
NVRO | $13.22 3.36% 76K
|
Health Technology
|
| O: -0.55%
H: 0.16%
C: -2.69%
conference report financial results
Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
EVGN | $0.7 -13.64% 63K
|
Health Technology
| Email alert
Add to watchlist
meeting
Veracyte Announces that Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
VCYT | News | $19.8 -0.15% 28K
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: -1.41%
bladder
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
UTHR | $237.8 1.42% 28K
|
Health Technology
|
| O: -0.41%
H: 0.0%
C: -1.0%
conference international commercial therapeutics
Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
TARO | $42.14 -0.21% 910
|
Health Technology
|
| O: 0.19%
H: 0.28%
C: 0.0%
approval for meeting
Can-Fite: Scientific Article Published by KOL Presents Namodenoson as a Promising Drug Candidate to Treat Advanced Liver Cancer and MASH
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
CANF | $1.96 -0.51% 310
|
Health Technology
|
| O: 4.76%
H: 0.45%
C: -5.91%
drug candidate liver cancer treat namodenoson advanced
Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-12 (Crawled : 13:00) - biospace.com/
VTRS | News A | $11.29 -0.62% 580K
|
Health Technology
|
| O: -0.17%
H: 0.17%
C: -1.9%
RVNC | $3.7 1.09% 160K
|
Health Technology
|
| O: -2.01%
H: 1.37%
C: -5.92%
daxxify neurology meeting
AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA®) for Preventive Treatment of Migraine
Published: 2024-04-12 (Crawled : 13:00) - biospace.com/
ABBV | News | $168.635 -0.53% 440K
|
Health Technology
|
| O: -1.92%
H: 0.0%
C: 0.0%
qulipta abbvie treatment for migraine
Oncocyte Reports Full Year 2023 Financial ResultsConference Call on Friday, April 12, 2024 at 5:00 a.m. PT / 8:00 a.m. ET
Published: 2024-04-12 (Crawled : 11:00) - biospace.com/
BIO | $281.99 -1.15% 28K
|
Health Technology
|
| O: -5.2%
H: 0.24%
C: -2.79%
OCX | News | $2.38 -3.06% 16K
|
Health Technology
|
| O: 7.93%
H: 3.12%
C: -15.31%
year financial
Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography
Published: 2024-04-11 (Crawled : 19:00) - biospace.com/
HOLX | $77.02 -0.22% 44K
|
Health Technology
|
| O: 0.73%
H: 0.09%
C: -0.51%
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
Published: 2024-04-11 (Crawled : 19:00) - biospace.com/
EDSA | $4.465 1.6K
|
Health Technology
|
| O: -3.95%
H: 0.0%
C: -0.44%
conference biotech
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
CZOO | $11.44 129.26% 4.6M
|
AMST | $3.4 70.0% 51M
|
Technology Services
BOF | $1.78 52.14% 15M
|
SYRA | $1.5 51.23% 1M
|
n/a
CSSE 4 | $0.23 51.02% 46M
|
Consumer Services
RILY | $30.325 39.62% 6.8M
|
Finance
LICN | $0.76 35.71% 6.2M
|
TROO | $1.41 29.36% 280K
|
Manufacturing
MULN | News | $3.53 29.3% 4.8M
|
Information
PROP | $14.84 25.55% 160K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.